High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation

British Journal of Haematology

Volumn 126, Issue 4, 2004, Pages 487-494

  Nilsson, Therese ^a   Lenhoff, Stig ^a   Rylander, Lars ^a   Höglund, Mattias ^a   Turesson, Ingemar ^a   Mitelman, Felix ^a   Westin, Jan ^a   Johansson, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Direct preparation; Karyotype; Monoclonal gammopathy of undetermined significance; Myeloma

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME PREPARATION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; MALE; METAPHASE CHROMOSOME; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; DEMECOLCINE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS;

EID: 4143117783     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05060.x     Document Type: Article

References (47)

1. Ankathil, R., Madhavan, J., Gangadharan, V.P., Rajasekharan Pillai, G. & Krishnan Nair, M. (1995) Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer and Genetics Cytogenetics, 83, 71-74.
2. Avet-Loiseau, H., Andree-Ashley, L.E., Moore, D. II, Mellerin, M.P., Feusner, J., Bataille, R. & Pallavicini, M.G. (1997) Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes, Chromosomes and Cancer, 19, 124-133.
3. Avet-Loiseau, H., Facon, T., Daviet, A., Godon, C., Rapp, M.J., Harousseau, J.L., Grosbois, B. & Bataille, R. (1999) 14q32 translocations and monosomy 13 in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Cancer Research, 59, 4546-4550.
4. Barbouti, A., Ahlgren, T., Johansson, B., Höglund, M., Lassen, C., Turesson, I., Mitelman, F. & Fioretos, T. (2003) Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. British Journal of Haematology, 122, 85-93.
5. Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. & Kuehl, W.M. (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 93, 13931-13936.
6. Biggar, R.J., Lee, E.C., Nkrumah, F.K. & Whang-Peng, J. (1981) Direct cytogenetic studies by needle aspiration of Burkitt's lymphoma in Ghana, West Africa. Journal of the National Cancer Institute, 67, 769-776.
7. Calasanz, M.J., Cigudosa, J.C., Odero, M.D., Ferreira, C., Ardanaz, M.T., Fraile, A., Carrasco, J.L., Solé, F., Cuesta, B. & Gullon, A. (1997) Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes, Chromosomes and Cancer, 18, 84-93.
8. Carbone, P., Caradonna, F., Granata, G., Marcenò, R., Cavallaro, A.M. & Barbata, G. (1992) Chromosomal abnormalities in Waldenström's macroglobulinemia. Cancer Genetics and Cytogenetics, 61, 147-151.
9. Cigudosa, J.C., Calasanz, M.J., Odero, M.D., Prosper, F., Etxaniz, A., Marin, J., Rifón, J., Gullón, A. & Rocha, E. (1994) Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters. Cancer Genetics and Cytogenetics, 78, 210-213.
10. Clark, R.E., Geddes, A.D., Whittaker, J.A. & Jacobs, A. (1989) Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. European Journal of Cancer Clinical Oncology, 25, 1789-1793.
11. Cuneo, A., Balsamo, R., Roberti, M.G., Bardi, A., Piva, N., Balboni, M., Bigoni, R., Rigolin G.M. & Castoldi, G. (1996) Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients. Cancer Genetics and Cytogenetics, 90, 171-175.
12. Dewald, G.W., Broderick, D.J., Tom, W.W., Hagstrom, J.E. & Pierre, R.V. (1985) The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genetics and Cytogenetics, 18, 1-10.
13. Drach, J., Angerler, J., Schuster, J., Rothermundt, C., Thalhammer, R., Haas, O.A., Jäger, U., Fiegl, M., Geissler, K. & Ludwig, H. (1995) Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood, 86, 3915-3921.
14. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
15. Facon, T., Laï, J.L., Nataf, E., Preudhomme, C., Zandecki, M., Hammad, M., Wattel, E., Jouet, J.P. & Bauters, F. (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report of 46 patients. British Journal of Haematology, 84, 743-745.
16. Ferti, A., Panani, A., Arapakis, G. & Raptis, S. (1984) Cytogenetic study in multiple myeloma. Cancer Genetics and Cytogenetics, 12, 247-253.
17. Flactif, M., Zandecki, M., Laï, J.L., Bernardi, F., Obein, V., Bauters, F. & Facon, T. (1995) Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia, 9, 2109-2114.
18. Fonseca, R., Bailey, R.J., Ahmann, G.J., Rajkumar, V., Hoyer, J.D., Lust, J.A., Kyle, R.A., Gertz, M.A., Greipp, P.R. & Dewald, G.W. (2002) Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood, 100, 1417-1424.
19. Gutiérrez, N.C., Hernández, J.M., Garcia, J.L., Almeida, J., Mateo, G., Gonzalez, M.I., Hernández, J., Hernández-Calvo, J. & San Miguel, J.F. (2000) Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells. Haematologica, 85, 1146-1152.
20. Harnden, D.G. (1974) Skin culture and solid tumor technique. In: Human Chromosome Methodology, 2nd edn (ed. by J.J. Yunis), pp. 167-182. Academic Press, New York and London.
21. Hernández, J.M., Guitérrez, N.C., Almeida, J., Garcia, J.L., Sanchez, M.A., Mateo, G., Rios, A. & San Miguel, J.F. (1998) IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases. British Journal of Haematology, 103, 163-167.
22. Hill, S.M., Rodgers, C.S. & Hultén, M.A. (1987) Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/tetraploid range investigated using direct preparations. Cancer Genetics and Cytogenetics, 24, 45-62.
23. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman), pp. 1-114. S. Karger, Basel.
24. Königsberg, R., Ackermann, J., Kaufmann, H., Zojer, N., Urbauer, E., Kromer, E., Jäger, U., Gisslinger, H., Schreiber, S., Heinz, R., Ludwig, H., Huber, H. & Drach, J. (2000) Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia, 14, 1975-1979.
25. Kowalczyk, J.R., Dmoszynska, A., Chobotow, M. & Sokolowska, B. (1991) Cytogenetic studies in patients with multiple myeloma. Cancer Genetics and Cytogenetics, 55, 173-179.
26. Laï, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
27. Lloveras, E., Solé, F., Florensa, L., Besses, C., Espinet, B., Gil, M., Perez-Vila, M.E., Pedro, C., Abella, E., Sans-Sabrafen, J. & Woessner, S. (2002) Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance. Cancer Genetics and Cytogenetics, 132, 25-29.
28. Lu, Y.J., Xiao, S., Yan, Y.S., Fu, S.B., Liu, Q.Z. & Li, P. (1993) Direct chromosome analysis of 50 primary breast carcinomas. Cancer Genetics and Cytogenetics, 69, 91-99.
29. Mitelman, F., Johansson, B. & Mertens, F. (2004) Mitelman Database of Chromosome Aberrations in Cancer. WWW document. URL. http://cgap.nci.nih.gov/ Chromosomes/Mitelman
30. Nilsson, T., Lenhoff, S., Turesson, I., Rylander, L., Mitelman, F., Westin, J., Höglund, M. & Johansson, B. (2002) Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. European Journal of Haematology, 69, 345-353.
31. Nilsson, T., Höglund, M., Lenhoff, S., Rylander, L., Turesson, I., Westin, F., Mitelman, F. & Johansson, B. (2003) A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. British Journal of Haematology, 120, 960-969.
32. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, K. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526-534.
33. Petkovic, I., Agbor, P. & Hittelman, W.N. (1989) Simultaneous cell type identification and premature chromosome condensation analysis in a case of multiple myeloma. Cancer Genetics and Cytogenetics, 39, 203-217.
34. Philip, P., Drivsholm, A., Hansen, N.E., Jensen, M.K. & Killmann, S.A. (1980) Chromosomes and survival in multiple myeloma. A banding study of 25 cases. Cancer Genetics and Cytogenetics, 2, 243-257.
35. Rajkumar, S.V., Fonseca, R., Dewald, G.W., Therneau, T.M., Lacy, M.Q., Kyle, R.A., Greipp, P.R. & Gertz, M.A. (1999) Cytogenetic abnormalities correlate with the plasma cell labelling index and extent of bone marrow involvement in myeloma. Cancer Genetics and Cytogenetics, 113, 73-77.
36. Ranni, N.S., Slavutsky, I., Wechsler, A. & Brieux de Salum, S. (1987) Chromosome findings in multiple myeloma. Cancer Genetics and Cytogenetics, 25, 309-316.
37. Rasillo, A., Tabernero, M.D., Sanchez, M.L., Perez de Andres, M., Martin, A.M., Hernández, J., Moro, M.J., Fernandez-Calvo, J., Sayagues, J.M., Bortoluci, A., San Miguel, J.F. & Orfao, A. (2003) Fluorescence in situ hybridization analysis of anueploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Cancer, 97, 601-609.
38. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
39. Seong, C., Delasalle, K., Hayes, K., Weber, D., Dimopoulos, M., Swantkowski, J., Huh, Y., Glassman, A., Champlin, R. & Alexanian, R. (1998) Prognostic value of cytogenetics in multiple myeloma. British Journal of Haematology, 101, 189-194.
40. Shaughnessy, J., Tian, E., Sawyer, J., Bumm, K., Landes, R., Badros, A., Morris, C., Tricot, G., Epstein, J. & Barlogie, B. (2000) High incidence of chromosome 13 deletions in multiple myeloma detected by multiprobe interphase FISH. Blood, 96, 1505-1511.
41. Tabernero, D., San Miguel, J.F., Garzia-Sanz, M., Najera, L., Garcia-Isidoro, M., Perez-Simon, J.A., Gonzalez, M., Wiegant, J., Raap, A.K. & Orfao, A. (1996) Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes. American Journal of Pathology, 149, 153-161.
42. Tricot G, Sawyer JR, Jagannath S, Desikan KR, Siegel D, Naucke S, Mattox S, Bracy D, Munshi N, Barlogie B. (1997) Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. Journal of Clinical Oncology, 15, 2659-2666.
43. Weh, H.J., Fiedler, W. & Hossfeld, D.K. (1990) Cytogenetics in multiple myeloma: are we studying the 'right' cells? European Journal of Haematology, 45, 236-237.
44. Williams, D.L., Harris, A., Williams, K.J., Brosius, M.J. & Lemonds, W. (1984) A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 13, 239-257.
45. Xia, J.C., Lu, S., Geng, J.S., Fu, S.B., Li, P. & Liu, Q.Z. (1998) Direct chromosome analysis often primary gastric cancers. Cancer Genetics and Cytogenetics, 102, 88-90.
46. Zandecki, M., Obein, V., Bernardi, F., Soenen, C., Flactif, M., Laï, J.L., Francois, M. & Facon, T. (1995) Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells. British Journal of Haematology, 90, 693-696.
47. Zandecki, M., Laï, J.L. & Facon, T. (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. British Journal of Haematology, 94, 217-227.